Assessment of how pregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotype women

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 4, 2008, Pages 347-351

  Montenegro, Marcelo Freitas ^a   Barbosa Jr , Fernando ^a   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GUANINE; LEAD; PORPHOBILINOGEN SYNTHASE;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FETUS; GENOTYPE; HUMANS; LEAD; MATERNAL-FETAL EXCHANGE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PORPHOBILINOGEN SYNTHASE; PREGNANCY; RISK ASSESSMENT;

EID: 40849131056     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00205.x     Document Type: Article

References (21)

1. Lamadrid-Figueroa H, Tellez-Rojo MM, Hernandez-Cadena L et al. Biological markers of fetal lead exposure at each stage of pregnancy. J Toxicol Environ Health A 2006 9 : 1781 96.
2. Popovic M, McNeill FE, Chettle DR, Webber CE, Lee CV, Kaye WE. Impact of occupational exposure on lead levels in women. Environ Health Perspect 2005 113 : 478 84.
3. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Korsch MJ, Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med 1997 130 : 51 62.
4. Tellez-Rojo MM, Hernandez-Avila M, Lamadrid-Figueroa H et al. Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol 2004 160 : 668 78.
5. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect 1991 91 : 17 32.
6. Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect 1991 91 : 33 7.
7. Banks EC, Ferretti LE, Shucard DW. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology 1997 18 : 237 81.
8. Schnaas L, Rothenberg SJ, Flores MF et al. Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect 2006 114 : 791 7.
9. Barbosa F Jr., Tanus-Santos JE, Gerlach RF, Parsons PJ. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005 113 : 1669 74.
10. Chuang HY, Schwartz J, Gonzales-Cossio T et al. Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect 2001 109 : 527 32.
11. Smith D, Hernandez-Avila M, Tellez-Rojo MM, Mercado A, Hu H. The relationship between lead in plasma and whole blood in women. Environ Health Perspect 2002 110 : 263 8.
12. Barbosa F Jr., Ramires I, Rodrigues MH et al. Contrasting effects of age on the plasma/whole blood lead ratio in men and women with a history of lead exposure. Environ Res 2006 102 : 90 5.
13. Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. Environ Health Perspect 2000 108 : 23 8.
14. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol 2001 154 : 1 13.
15. Wetmur JG, Kaya AH, Plewinska M, Desnick RJ. Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 1991 49 : 757 63.
16. Montenegro MF, Barbosa F Jr., Sandrim VC, Gerlach RF, Tanus-Santos JE. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Arch Toxicol 2006 80 : 394 8.
17. Montenegro MF, Barbosa F Jr., Sandrim VC, Gerlach RF, Tanus-Santos JE. Ethnicity affects the distribution of delta-aminolevulinic acid dehydratase (ALAD) genetic variants. Clin Chim Acta 2006 367 : 192 5.
18. Barbosa F Jr., Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations. Basic Clin Pharmacol Toxicol 2006 98 : 559 64.
19. Barbosa F Jr., Sandrim VC, Uzuelli JA, Gerlach RF, Tanus-Santos JE. eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations. Nitric Oxide 2006 14 : 58 64.
20. Barbosa F Jr., Sartorio JTC, Gerlach RF, Tanus-Santos JE. Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch Toxicol 2006 80 : 811 6.
21. Gulson BL, Mizon KJ, Palmer JM, Korsch MJ, Taylor AJ, Mahaffey KR. Blood lead changes during pregnancy and postpartum with calcium supplementation. Environ Health Perspect 2004 112 : 1499 507.